Consult the medical resource doctors trust
UpToDate is one of the most respected medical information resources in the world, used by over 360,000 doctors and thousands of patients to find answers to medical questions.
Related articles included with a subscription
![]() | Preview Available (subscription required for full access) |



















Related Searches
| AuthorMarie R Baldisseri, MD, FCCM | Section EditorsScott Manaker, MD, PhDCharles J Lockwood, MD | Deputy EditorKevin C Wilson, MD |
As a subscriber you will have access to the full contents of this article
Amniotic fluid embolism syndrome (also called anaphylactoid syndrome of pregnancy) is a catastrophic condition that occurs during pregnancy or shortly after delivery [1,2]. Although first reported in 1926, it was not widely recognized until 1941 when an autopsy series of eight women who had died from sudden shock during labor reported squamous cells and mucin of fetal origin in the maternal pulmonary vasculature [3,4]. Fetal squamous cells have also been described in the vascular beds of the maternal kidneys, liver, spleen, pancreas, and brain [5].
Amniotic fluid embolism syndrome is reviewed here. The management of critically ill obstetric patients is discussed separately, including those with venous thromboembolism. (See "Critical illness during pregnancy and peripartum" and "Deep vein thrombosis and pulmonary embolism in pregnancy: Treatment".)
Amniotic fluid embolism syndrome is rare. Most studies estimate that one case occurs in every 8000 to 80,000 deliveries [6-9]. As an example, one retrospective cohort study of three million birth records identified 7.7 cases per 100,000 births [6].
Several factors have been associated with amniotic fluid embolism syndrome. They include precipitous or tumultuous labor, advanced maternal age, cesarean and instrumental delivery, placenta previa and abruption, grand multiparity (≥5 live births or stillbirths), cervical lacerations, fetal distress, eclampsia, and medical induction of labor [6,10]. Despite the associations, our current understanding of the pathogenesis suggests that these factors probably are not the cause of amniotic fluid embolism syndrome. The syndrome is best considered unpredictable and unpreventable.
Amniotic fluid probably enters the maternal circulation through the endocervical veins, the placental insertion site, or a site of uterine trauma [11]. Once it reaches the maternal circulation, it can precipitate cardiogenic shock, respiratory failure, and, possibly, an inflammatory response.
| References |
Top
|
![]() |
Please wait |